BioReliance Updates Big Blue Mouse Assay Service

Article

BioReliance updates Big Blue Mouse Assay service to meet OECD test requirements.


SPOTLIGHT EVENT

IVT’s 19th AnnualValidation Week

RELATED ARTICLES

More in GMPs/Validation

BioReliance

, SAFC’s biologics and early-development services business, has qualified the Big Blue Mouse Transgenic Rodent Mutation (TRM) assay to meet the new Organization for Economic Co-Operation and Development (OECD) Test Guideline 488 requirements for evaluation of

in vivo

mutagenicity.

Big Blue is identified in OECD Test Guideline 488 and recommended by the European Chemicals Agency as an accepted assay for evaluating mutagenicity in somatic and male germ cell tissues.

BioReliance acquired the exclusive ownership of the Big Blue TRM assay and rodents from Agilent in March 2013.

Source: BioReliance

Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Behind the Headlines, Episode 10
Behind the Headlines episode 8
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content